The Nitinol Medical Devices Market is expected to register a CAGR of 9.1% over the forecast period. Growing burden of diseases and increasing adoption of minimally invasive surgeries is expected to propel the global nitinol medical devices market growth. Nitinol known for its super-elasticity, has wide number of applications in the healthcare industry. According to the World Health Organization, cardiovascular disease is the major cause of death worldwide and around 17.9 million people die due to it. With the higher burden of diseases such as cardiovascular disorders, renal lithiasis, etc., the demand for nitinol medical devices is also expected to increase. However, the presence of alternative to these devices may impel the nitinol medical devices market growth.
Key Market Trends Stents Segment is Expected to Hold a Major Share in the Nitinol medical Devices Market
• Stents are tiny tubes that are used for insertion into a blocked passageway. Nitinol stents exhibit some unique properties that makes it more efficient than other stents. These stents are engineered in such a way that when inserted, it adjusts itself into the wall of the vessel and resists it’s forces. Also, these stents are less corrosive even though there is a presence of nickel.
• According to the American Cancer Society, approximately 18,440 new cases have been diagnosed with esophageal cancer for the year 2020, in the United States. Such factors helps the care providers to use better stents in the market where the nitinol stents are useful and commonly due to its self-expanding characteristic, thereby, expected to drive the stents segment.
• Furthermore, adoption of minimally invasive surgeries is expected to influence positively on the nitinol stents segment. For instance, angioplasty is a minimal invasive surgery that requires a balloon tipped catheter to insert into a blocked vessel and a stent to inflate the balloon. According to the study of Eurostat, in 2017, around 1.2 million procedures related to transluminal coronary angioplasty were conducted.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to be a dominant region in nitinol medical devices market growth due to the growing burden of diseases and increase in adoption of minimally invasive procedures. Coronary heart disease also known as ischemic heart disease is caused due to formation of plaque in the wall of arteries. According to the Centre for Disease Control and Prevention, coronary artery disease is one of the most affected heart diseases in the United States. In coronary artery disease, plaque builds up and blocks the arteries as a result there is improper flow of blood. For removal of these blockages generally stents are used. Hence, these factor is expected to impact positively on the nitinol medical devices market growth in this particular region.
Competitive Landscape The Nitinol medical Devices Market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are EndoSmart GmbH, Boston Scientific Inc., B. Braun Melsungen, Arthrex Inc., Zimmer Biomet, Cook Medical, Terumo IS, Merck KGaA, Becton, Dickinson & Company and W.L. Gore & Associate Inc.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
Spain General Surgery Procedures Outlook to 2025 - Aesthetic Filler, Aesthetic Filler, Airway Stent and Others Summary “Spain General Surgery Procedures Outlook to 2025” is a comprehensive databook report, covering key procedures data on the Spain General Surgery Procedures. The databook report provides...
Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products...
The South & Central America Medical Devices market is expected to reach US$ 24,642.7 million in 2027 from US$ 17,612.3 million in 2019; it is estimated to grow at a CAGR of 4.4% from 2020 to 2027. The growing aging population leads to several chronic conditions such as cancer, orthopedic conditions, neurodegenerative disorders, and diabetes...
Troponin Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Troponin Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Troponin Tests pipeline products with comparative analysis of the products at various stages...
Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Intraocular Lens (IOL) pipeline products with comparative analysis of the products...
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
266 pages •
By The Business Research Company
• Dec 2020
Dialysis Devices And Equipment Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global dialysis devices and equipment market. Description: Where is the largest and fastest...
Mexico Clot Management Devices Market Outlook to 2025 - CDT Catheters, Embolectomy Balloon Catheters, Inferior Vena Cava Filters (IVCF) and Others Summary “Mexico Clot Management Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Mexico Clot Management...
The Europe hospital gowns market is expected to reach US$ 1,467.78 million by 2027 from US$ 875.57 million in 2019. The market is expected to grow at a CAGR of 6.8% during 2020–2027. Increasing number of surgeries and rising initiatives to support the health protection of patients from hospital-acquired infections in Europe are driving the...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.